MOTT RICHARD W 4
4 · TREACE MEDICAL CONCEPTS, INC. · Filed Jan 30, 2023
Insider Transaction Report
Form 4
MOTT RICHARD W
Director
Transactions
- Sale
Common Stock
2023-01-30$23.87/sh−27,422$654,602→ 1,161,050 total - Sale
Common Stock
2023-01-30$24.58/sh−2,039$50,120→ 1,159,011 total - Sale
Common Stock
2023-01-30$22.92/sh−61,528$1,410,449→ 1,188,472 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.4000 to $23.3950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes 2,295 RSUs.
- [F4]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $23.4100 to $24.4000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4150 to $25.1300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.